Evolent Health (NYSE: EVH)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.120 | ||||||
REV | 286.770M | 297.057M | 10.287M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Evolent Health (NYSE: EVH) through any online brokerage.
Other companies in Evolent Health’s space includes: Change Healthcare (NASDAQ:CHNG), MultiPlan (NYSE:MPLN), GoodRx Holdings (NASDAQ:GDRX), OptimizeRx (NASDAQ:OPRX) and Pear Therapeutics (NASDAQ:PEAR).
The latest price target for Evolent Health (NYSE: EVH) was reported by Cowen & Co. on Tuesday, June 21, 2022. The analyst firm set a price target for 50.00 expecting EVH to rise to within 12 months (a possible 58.48% upside). 6 analyst firms have reported ratings in the last year.
The stock price for Evolent Health (NYSE: EVH) is $31.55 last updated June 24, 2022, 7:59 PM UTC.
There are no upcoming dividends for Evolent Health.
Evolent Health’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Evolent Health.
Evolent Health is in the Health Care sector and Health Care Technology industry. They are listed on the NYSE.